Literature DB >> 25787087

KDM1 class flavin-dependent protein lysine demethylases.

Jonathan M Burg1, Jennifer E Link1, Brittany S Morgan1, Frederick J Heller1, Amanda E Hargrove1, Dewey G McCafferty1.   

Abstract

Flavin-dependent, lysine-specific protein demethylases (KDM1s) are a subfamily of amine oxidases that catalyze the selective posttranslational oxidative demethylation of methyllysine side chains within protein and peptide substrates. KDM1s participate in the widespread epigenetic regulation of both normal and disease state transcriptional programs. Their activities are central to various cellular functions, such as hematopoietic and neuronal differentiation, cancer proliferation and metastasis, and viral lytic replication and establishment of latency. Interestingly, KDM1s function as catalytic subunits within complexes with coregulatory molecules that modulate enzymatic activity of the demethylases and coordinate their access to specific substrates at distinct sites within the cell and chromatin. Although several classes of KDM1-selective small molecule inhibitors have been recently developed, these pan-active site inhibition strategies lack the ability to selectively discriminate between KDM1 activity in specific, and occasionally opposing, functional contexts within these complexes. Here we review the discovery of this class of demethylases, their structures, chemical mechanisms, and specificity. Additionally, we review inhibition of this class of enzymes as well as emerging interactions with coregulatory molecules that regulate demethylase activity in highly specific functional contexts of biological and potential therapeutic importance.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epigenetic; KDM1A; KDM1B; LSD1; LSD2

Mesh:

Substances:

Year:  2015        PMID: 25787087      PMCID: PMC4747437          DOI: 10.1002/bip.22643

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  347 in total

Review 1.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

2.  Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Authors:  Philip Kahl; Lucia Gullotti; Lukas Carl Heukamp; Susanne Wolf; Nicolaus Friedrichs; Roland Vorreuther; Gerold Solleder; Patrick J Bastian; Jörg Ellinger; Eric Metzger; Roland Schüle; Reinhard Buettner
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

3.  Doxorubicin enhances Snail/LSD1-mediated PTEN suppression in a PARP1-dependent manner.

Authors:  Yiwei Lin; Tiebang Kang; Binhua P Zhou
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

4.  A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes.

Authors:  Sujit S Nair; Da-Qiang Li; Rakesh Kumar
Journal:  Mol Cell       Date:  2013-01-24       Impact factor: 17.970

Review 5.  The histone LSD1 demethylase in stemness and cancer transcription programs.

Authors:  Stefano Amente; Luigi Lania; Barbara Majello
Journal:  Biochim Biophys Acta       Date:  2013-05-16

6.  Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway.

Authors:  Da-Qiang Li; Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Shao-Hua Peng; Yi Lian; Sidney W Fu; Rakesh Kumar
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

7.  Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.

Authors:  Tangfeng Lv; Dongmei Yuan; Xiaohui Miao; Yanling Lv; Ping Zhan; Xiaokun Shen; Yong Song
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

8.  Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.

Authors:  Jun-Tang Li; Li-Feng Wang; Ya-Li Zhao; Tao Yang; Wei Li; Jing Zhao; Feng Yu; Lei Wang; Yan-Ling Meng; Ning-Ning Liu; Xiao-Shan Zhu; Chun-Fang Gao; Lin-Tao Jia; An-Gang Yang
Journal:  Breast Cancer Res       Date:  2014-10-14       Impact factor: 6.466

9.  SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors.

Authors:  Jin Zhang; Roberto Bonasio; Francesco Strino; Yuval Kluger; J Kim Holloway; Andrew J Modzelewski; Paula E Cohen; Danny Reinberg
Journal:  Genes Dev       Date:  2013-04-01       Impact factor: 11.361

10.  Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast.

Authors:  Nuran Serce; Annette Gnatzy; Susanne Steiner; Henning Lorenzen; Jutta Kirfel; Reinhard Buettner
Journal:  BMC Clin Pathol       Date:  2012-08-24
View more
  20 in total

1.  Activity-dependent Regulation of Histone Lysine Demethylase KDM1A by a Putative Thiol/Disulfide Switch.

Authors:  Emily L Ricq; Jacob M Hooker; Stephen J Haggarty
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  Hypoxia favors the generation of human plasma cells.

Authors:  Matthieu Schoenhals; Michel Jourdan; Angélique Bruyer; Alboukadel Kassambara; Bernard Klein; Jérôme Moreaux
Journal:  Cell Cycle       Date:  2017-05-02       Impact factor: 4.534

3.  A rationally-designed chimeric KDM1A/KDM1B histone demethylase tower domain deletion mutant retaining enzymatic activity.

Authors:  Jonathan M Burg; Alan T Makhoul; Charles W Pemble; Jennifer E Link; Frederick J Heller; Dewey G McCafferty
Journal:  FEBS Lett       Date:  2015-07-29       Impact factor: 4.124

4.  Lysine-Specific Demethylase 1A (KDM1A/LSD1): Product Recognition and Kinetic Analysis of Full-Length Histones.

Authors:  Jonathan M Burg; Julie J Gonzalez; Kenneth R Maksimchuk; Dewey G McCafferty
Journal:  Biochemistry       Date:  2016-02-09       Impact factor: 3.162

5.  Towards the development of activity-based probes for detection of lysine-specific demethylase-1 activity.

Authors:  Maria E Ourailidou; Alessia Lenoci; Clemens Zwergel; Dante Rotili; Antonello Mai; Frank J Dekker
Journal:  Bioorg Med Chem       Date:  2016-12-01       Impact factor: 3.641

Review 6.  Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.

Authors:  Hideaki Niwa; Takashi Umehara
Journal:  Epigenetics       Date:  2017-02-10       Impact factor: 4.528

7.  Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni.

Authors:  Vitor Coutinho Carneiro; Isabel Caetano de Abreu da Silva; Murilo Sena Amaral; Adriana S A Pereira; Gilbert Oliveira Silveira; David da Silva Pires; Sergio Verjovski-Almeida; Frank J Dekker; Dante Rotili; Antonello Mai; Eduardo José Lopes-Torres; Dina Robaa; Wolfgang Sippl; Raymond J Pierce; M Teresa Borrello; A Ganesan; Julien Lancelot; Silvana Thiengo; Monica Ammon Fernandez; Amanda Roberta Revoredo Vicentino; Marina Moraes Mourão; Fernanda Sales Coelho; Marcelo Rosado Fantappié
Journal:  PLoS Negl Trop Dis       Date:  2020-07-01

8.  Folate deficiency affects histone methylation.

Authors:  Benjamin A Garcia; Zigmund Luka; Lioudmila V Loukachevitch; Natarajan V Bhanu; Conrad Wagner
Journal:  Med Hypotheses       Date:  2016-01-09       Impact factor: 1.538

Review 9.  Epigenetic polypharmacology: from combination therapy to multitargeted drugs.

Authors:  Angel R de Lera; A Ganesan
Journal:  Clin Epigenetics       Date:  2016-10-12       Impact factor: 6.551

10.  Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex.

Authors:  Mingxuan Wu; Dawn Hayward; Jay H Kalin; Yun Song; John Wr Schwabe; Philip A Cole
Journal:  Elife       Date:  2018-06-05       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.